English
+86-21-68129666     international@chemtronbio.com
Buy Best Rapid Diagnostic Test for OTC Use At Home | Shanghai Chemtron Biotech
English
Menu
What are you looking for?
Your Position:Home>Products>Qutantative Test>cTnI quantitative rapid test-Cardiac Troponin I Diagnostic Kit
Contact Us

+86-21-68129666

+86-21-68129333

No.518, Qingdai Rd., International Medical Park, Pudong, 201318, Shanghai, P.R.China

international@chemtronbio.com

  • Buy Best Rapid Diagnostic Test for OTC Use At Home | Shanghai Chemtron Biotech

cTnI quantitative rapid test-Cardiac Troponin I Diagnostic Kit

  • ctni-troponin-i-quantitative-rapid-test

Features:

Specimen: Serum/Plasma
Specimen volume: 80μl
Detection range: 1-50ng/ml
Reference value: <1ng/ml
Precision: CV<15%
Accuracy: Relative deviation <20%

Contact Now
  • Product Detail

Product Profile of cTnI quantitative rapid test-Cardiac Troponin I Diagnostic Kit
Chemtrue® cTnI Diagnostic Kit adopts the technology of colloidal gold chromatographic immunoassay and principle of double-antibody sandwich to detect the level of cTnI in serum and plasma specimens. Combined with ECG and clinical symptoms, it can be used in clinical early diagnosis of AMI, UAP, acute myocarditis and ACS.

Product Property of cTnI quantitative rapid test-Cardiac Troponin I Diagnostic Kit
Specimen: Serum/Plasma
Specimen volume: 80μl
Detection range: 1-50ng/ml
Reference value: <1ng/ml
Precision: CV<15%
Accuracy: Relative deviation <20%
Interpretation time: 15min
Test time: 15s

Product Advantages of cTnI quantitative rapid test-Cardiac Troponin I Diagnostic Kit
A preferred index of AMI diagnosis;
One-step rapid testing, and effectively reduce TAT to give patients timely therapy;
Strong ability to anti-interference;
Advanced testing method of double-antibody sandwich.

Clinical Applications of cTnI quantitative rapid test-Cardiac Troponin I Diagnostic Kit
Clinical diagnosis, prognosis evaluation and risk stratification of Acute Coronary Syndrome;
To measure the area of MI;
To monitor myocardial damage caused by cardiac operation;
To evaluate the effect of thrombolytic therapy;
To detect that cardiac dissolution in non-ischemic heart failure;
A new marker for left-ventricular hypertrophy in primary hypertension.